A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese
Open Access
- 22 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 31 (4), 450-454
- https://doi.org/10.1038/aps.2010.25
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) studyDiabetologia, 2009
- Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese populationDiabetologia, 2009
- Neuronal Nitric Oxide Synthase Activation Is Involved in Insulin-Mediated Cardiovascular Effects in the Nucleus Tractus Solitarii of RatsNeuroscience, 2009
- Association ofKCNJ11andABCC8genetic polymorphisms with response to repaglinide in Chinese diabetic patients1Acta Pharmacologica Sinica, 2008
- Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric OxideScience, 2003
- Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide SynthaseCirculation, 2001
- A Neuronal Isoform of Nitric Oxide Synthase Expressed in Pancreatic β-Cells Controls Insulin SecretionDiabetes, 2001
- The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitusDiabetes/Metabolism Research and Reviews, 2001
- Insulin, nitric oxide and the sympathetic nervous systemJournal of Hypertension, 1999
- Endogenous nitric oxide synthesis: Biological functions and pathophysiologyFree Radical Research, 1999